Radiobiologically based assessments of the net costs of fractionated radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 3, 1996, Pages 739-746

  Dale, Roger G ^a   Jones, Bleddyn ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

Cost optimization; Economic issues; Fractionation; Linear quadratic; Radiobiological modeling

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CANCER RADIOTHERAPY; COST BENEFIT ANALYSIS; COST CONTROL; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE; TREATMENT PLANNING;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; LINEAR MODELS; MODELS, ECONOMIC; NEOPLASMS; RADIOBIOLOGY; RADIOTHERAPY;

EID: 0030266399     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00375-6     Document Type: Article

References (16)

1. 1. Barton, M. B.; Gebski, V.; Manderson, C.; Langlands, A. O. Radiation therapy: Are we getting value for money? Clin. Oncol. 7:287-292; 1995.
2. 2. Chappell, R.; Nondahl, D. M.; Rezvani, M.; Fowler, J. F. Further analysis of radiobiological parameters from the first and second British Institute of Radiology randomised studies of larynx/pharynx radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 33(2):509-518; 1995.
3. 3. Dale, R. G. The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day. Br. J. Radiol. 59:919-927; 1986.
4. 4. Dale, R. G. Time-dependent tumour repopulation factors in linear-quadratic equations-Implications for treatment strategies. Radiother. Oncol. 15:371-382; 1989.
5. 5. Dale, R. G.; Jones, B. Implications of overall time in radiotherapy. (Editorial). Clin. Oncol. 5:339-340; 1993.
6. 6. Fowler, J. F. The linear quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62:679-694; 1989.
7. 7. Fowler, J. F. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations. Radiother. Oncol. 18:165-181; 1990.
8. 8. Glazebrook, G. A. Radiation therapy: A long term cost benefit analysis in a North American region. Clin. Oncol. 4:302-305; 1992.
9. 9. Jones, B.; Tan, L. T.; Dale, R. G. Derivation of the optimum dose per fraction from the linear quadratic model. Br. J. Radiol. 68:894-902; 1995.
10. 10. Ling, C. C.; Fuks, Z. Conformal radiation treatment: A critical appraisal. Eur. J. Cancer. 31(A5):799-803; 1995.
11. 11. Munro, A. J. The cost of hyperfractionation: An economic analysis incorporating consideration of waiting time for treatment. Clin. Oncol. 7:162-167; 1995.
12. 12. Peters, L. J. Through a glass darkly: Predicting the future of radiation oncology. Int. J. Radiat. Oncol. Biol. Phys. 31(2):219-225; 1995.
13. 13. Read, G. Estimating the cost of radiotherapy. Clin. Oncol. 6:35-39; 1994.
14. 14. Read, G. Radiotherapy: Effective treatment at low cost! Clin. Oncol. 7:275-276; 1995.
15. 15. Thames, H. D. An "incomplete-repair model for survival after fractionated and continuous irradiation's. Int. J. Radiat. Oncol. Biol. Phys. 47:319-339; 1985.
16. 16. Withers, H. R.; Peters, L. J.; Taylor, M. G.; Owen, J. B.; Morrison, W. H.; Schultheiss, T. E.; et al. Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions. Int. J. Radiat. Oncol. Biol. Phys. 33(3):549-562; 1995.